| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051798313 |
| P356 | DOI | 10.2165/00007256-200434080-00003 |
| P698 | PubMed publication ID | 15248788 |
| P5875 | ResearchGate publication ID | 8460137 |
| P2093 | author name string | Harm Kuipers | |
| Fred Hartgens | |||
| P2860 | cites work | Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study | Q28111974 |
| The incidence of anabolic steroid use among competitive bodybuilders | Q28265588 | ||
| Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids | Q28273389 | ||
| Anabolic steroid use and perceived effects in ten weight-trained women athletes | Q28308008 | ||
| Anabolic steroids | Q33716973 | ||
| Atrial fibrillation and anabolic steroids | Q33739880 | ||
| Cellular adaptation of the trapezius muscle in strength-trained athletes. | Q33856353 | ||
| Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial | Q33889238 | ||
| Testosterone dose-response relationships in healthy young men. | Q33955919 | ||
| Blood pressure and rate pressure product response in males using high-dose anabolic androgenic steroids (AAS). | Q33973772 | ||
| The dose-dependent effects of testosterone on sexual function and on muscle mass and function | Q34013938 | ||
| Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function | Q34015823 | ||
| Glucocorticoid antagonism by exercise and androgenic-anabolic steroids | Q34028976 | ||
| Response of serum hormones to androgen administration in power athletes | Q34048558 | ||
| Affective and psychotic symptoms associated with anabolic steroid use. | Q34049415 | ||
| Left ventricular size and function in body builders using anabolic steroids | Q34051528 | ||
| Anorexia nervosa and "reverse anorexia" among 108 male bodybuilders. | Q34060503 | ||
| The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. | Q34062583 | ||
| Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update | Q34063856 | ||
| The effect of supraphysiological doses of anabolic androgenic steroids on collagen metabolism | Q74231322 | ||
| Anabolic steroids impair the exercise-induced growth of the cardiac capillary bed | Q74231326 | ||
| Ventricular thrombosis and systemic embolism in bodybuilders: etiology and management | Q74255933 | ||
| Anabolic steroids: the gremlins of sport | Q74666340 | ||
| The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients | Q74800224 | ||
| Performance enhancing drugs (doping agents) and sudden death--a case report and review of the literature | Q77205482 | ||
| Anabolic steroid-induced hepatotoxicity: is it overstated? | Q77770464 | ||
| Androgenic-anabolic steroid-induced body changes in strength athletes | Q82569636 | ||
| Hypercholesterolemia in Male Power Lifters Using Anabolic-Androgenic Steroids | Q87873382 | ||
| Cardiomyopathy and Cerebrovascular Accident Associated With Anabolic-Androgenic Steroid Use | Q87902378 | ||
| [Acne fulminans following use of anabolic steroids] | Q93528609 | ||
| Anabolic androgenic steroids and suicide | Q93533969 | ||
| Androgenic-anabolic steroid effects on serum and skin surface lipids, on red cells, and on liver enzymes | Q70063362 | ||
| Liver carcinoma in an athlete taking anabolic steroids | Q70081127 | ||
| Carcinoma of the prostate | Q70171542 | ||
| Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy | Q70449324 | ||
| Effects of anabolic steroids and endurance exercise on cardiac performance | Q70498585 | ||
| Domestic violence associated with anabolic steroid abuse | Q70533918 | ||
| Anabolic steroid effects on body composition in normal young men | Q70544302 | ||
| Ingestion of androgenic-anabolic steroids induces mild thyroidal impairment in male body builders | Q70660321 | ||
| Left ventricular size and function in elite bodybuilders using anabolic steroids. | Q34064468 | ||
| Anabolic steroids: a review for the clinician | Q34121676 | ||
| Androgen abuse by athletes | Q34163640 | ||
| Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man. | Q34168246 | ||
| "Anabolic" effects of methandienone in men undergoing athletic training | Q34247729 | ||
| Effects of anabolic-androgenic steroids on the pilosebaceous unit | Q34251647 | ||
| Bilateral rupture of the quadriceps tendon associated with anabolic steroids | Q34264883 | ||
| Effects of methandienone on the performance and body composition of men undergoing athletic training | Q34276084 | ||
| Use of anabolic-androgenic steroids among body builders--frequency and attitudes | Q34334666 | ||
| Steroid use and long-term health risks in former athletes | Q34511060 | ||
| Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse | Q34530391 | ||
| Androgenic steroid effects on liver and red cells | Q34676817 | ||
| Hepatic tumours induced by anabolic steroids in an athlete | Q34681221 | ||
| Anabolic Steroids: Doctors Denounce Them, but Athletes Aren't Listening | Q34684114 | ||
| Maintenance immunosuppression after liver transplantation | Q35315279 | ||
| Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). | Q35328774 | ||
| The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action | Q35611154 | ||
| Left ventricular function is not impaired in weight-lifters who use anabolic steroids | Q35862816 | ||
| Liver pathology associated with the use of anabolic-androgenic steroids | Q35882322 | ||
| Atherogenic effects of anabolic steroids on serum lipid levels. A literature review | Q37417731 | ||
| Anabolic steroid-induced tendon pathology: a review of the literature | Q37647887 | ||
| The influence of testosterone on human aggression | Q37713565 | ||
| Anabolic-androgenic steroids | Q37783613 | ||
| Assessment of attentional bias and mood in users and non-users of anabolic-androgenic steroids | Q38463908 | ||
| The effects of anabolic steroids and strength training on the human immune response. | Q38690561 | ||
| Hooked on hormones? An anabolic steroid addiction hypothesis | Q38714365 | ||
| Steroid abuse in athletes, prostatic enlargement and bladder outflow obstruction--is there a relationship? | Q39370776 | ||
| Anabolic-androgenic steroid effects on endocrinology and lipid metabolism in athletes | Q39565648 | ||
| Hepatotoxic effects of the anabolic/androgenic steroids | Q39682198 | ||
| The history of anabolic steroids and a review of clinical experience with anabolic steroids | Q39836185 | ||
| Interaction of anabolic steroids with glucocorticoid receptor sites in rat muscle cytosol | Q39966107 | ||
| Wilms Tumor in an Adult Associated With Androgen Abuse | Q40067448 | ||
| Hepatic Lesions Caused by Anabolic and Contraceptive Steroids | Q40130806 | ||
| Anabolic steroids and athletics | Q40307595 | ||
| Stanozolol as a novel therapeutic agent in dermatology. | Q40452449 | ||
| Effects of exercise training on plasma lipids and lipoproteins | Q40632371 | ||
| Rhabdomyolysis in body building. Report of a case and literature review | Q44895020 | ||
| Ultrastructural and morphometric investigations on the effects of training and administration of anabolic steroids on the myocardium of guinea pigs | Q46689091 | ||
| Effect of continuous infusion of an anabolic steroid on murine skeletal muscle. | Q46695019 | ||
| Effect of testosterone and anabolic steroids on the size of sebaceous glands in power athletes | Q47188811 | ||
| Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids | Q47233978 | ||
| Side Effects of Anabolic Steroids in Weight-Trained Men. | Q47246837 | ||
| Effects of anabolic-androgenic steroids on weight-lifters' myocardium: an ultrasonic videodensitometric study | Q47266806 | ||
| History, chemistry and pharmacodynamics of anabolic-androgenic steroids | Q47274756 | ||
| Cardiovascular effects of anabolic steroids in weight-trained subjects | Q47320560 | ||
| Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters | Q47324002 | ||
| Anabolic steroid: effectiveness as an ergogenic aid to experienced weight trainers. | Q47356790 | ||
| The effects of an anabolic steroid on the strength, body composition, and endurance of college males when accompanied by a weight training program | Q47370720 | ||
| Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter | Q47408255 | ||
| Androgenic-anabolic steroid abuse and platelet aggregation: a pilot study in weight lifters | Q47417172 | ||
| Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes | Q47431660 | ||
| Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings | Q47440256 | ||
| Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters | Q47448559 | ||
| Self-Treatment of Gynecomastia in Bodybuilders Who Use Anabolic Steroids | Q47584573 | ||
| Effects of an androgenic-anabolic steroid on strength development and plasma testosterone levels in normal males. | Q48600504 | ||
| Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use | Q48882290 | ||
| Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis. | Q50927466 | ||
| Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. | Q51014706 | ||
| Social physique anxiety, body esteem, and social anxiety in bodybuilders and self-reported anabolic steroid users. | Q51118656 | ||
| Anabolic steroid use by amateur athletes: effects upon psychological mood states. | Q51131797 | ||
| Neuropsychiatric effects of anabolic steroids in male normal volunteers. | Q51141635 | ||
| Surgical correction of gynaecomastia in bodybuilders. | Q51600984 | ||
| Dietary influences on cardiovascular disease risk in anabolic steroid-using and nonusing bodybuilders. | Q51621391 | ||
| Anabolic steroids alter the haemodynamic effects of endurance training on the canine left ventricle. | Q51783039 | ||
| Psychiatric and medical effects of anabolic-androgenic steroid use in women. | Q51979095 | ||
| Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. | Q52026386 | ||
| Illicit anabolic steroid use in athletes. A case series analysis. | Q52056853 | ||
| Anabolic steroids and acute schizophrenic episode. | Q52104818 | ||
| Effects of anabolic steroids on the muscle cells of strength-trained athletes. | Q52172711 | ||
| Symptoms and correlates of anabolic-androgenic steroid dependence. | Q52265703 | ||
| Rupture of the triceps tendon associated with steroid injections | Q53526057 | ||
| Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection. | Q53622357 | ||
| Self-Reported Use of Anabolic-Androgenic Steroids by Elite Power Lifters. | Q53718513 | ||
| On the problem of influencing strength training with anabolic hormones | Q53853740 | ||
| The effect of anabolic steroid upon skeletal muscle contractile force | Q53871283 | ||
| Altered Serum Lipoprotein Profiles in Male and Female Power Lifters Ingesting Anabolic Steroids. | Q53888795 | ||
| Influence of exercise and Dianabol on the degradation rate of myofibrillar proteins of the heart and three fiber types of skeletal muscle of female guinea pigs. | Q53906584 | ||
| Anabolic steroids alter the haemodynamic effects of endurance training and deconditioning in rats. | Q54123680 | ||
| Resistance exercise effects on plasma cortisol, testosterone and creatine kinase activity in anabolic-androgenic steroid users. | Q54318482 | ||
| Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. | Q54407444 | ||
| Effects of androgenic-anabolic steroids on neuromuscular power and body composition. | Q54502193 | ||
| Glucose intolerance and insulin resistance in aplastic anemia treated with oxymetholone. | Q54529102 | ||
| Adaptation of human skeletal muscle to training and anabolic steroids. | Q55033710 | ||
| Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. | Q55060303 | ||
| Effect of testosterone on muscle mass and muscle protein synthesis. | Q55060315 | ||
| Narcissism and empathy in steroid users. | Q55063218 | ||
| Acute rhabdomyolysis due to body building exercise. Report of a case | Q40636707 | ||
| Cardiovascular toxicity of anabolic steroids | Q40908205 | ||
| Cardiovascular effects of androgenic-anabolic steroids. | Q40928946 | ||
| Androgen receptor: an overview | Q41000439 | ||
| Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature | Q41050491 | ||
| Update on urticaria and angioedema (hives). | Q41070091 | ||
| Anabolic steroids and the mind. | Q41084716 | ||
| Anabolic/androgenic steroid abuse and thrombosis: is there a connection? | Q41167010 | ||
| Resistance trained athletes using or not using anabolic steroids compared to runners: effects on cardiorespiratory variables, body composition, and plasma lipids | Q41322890 | ||
| Androgenic--anabolic steroids and body dysmorphia in young men. | Q41454592 | ||
| Influence of nandrolondecanoate on the pituitary-gonadal axis in males | Q41602402 | ||
| Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss | Q41609940 | ||
| Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial | Q41646733 | ||
| Anabolic‐Androgenic steroid abuse in weight lifters: Evidence for activation of the hemostatic system | Q41679561 | ||
| Unilateral gynecomastia induced by the use of anabolic steroids. A clinical case report | Q41786579 | ||
| A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis | Q41844359 | ||
| The short-term metabolic effects of strenuous exercise in bodybuilders | Q42063320 | ||
| A double-blind crossover trial of methandienone (Dianabol, CIBA) in moderate dosage on highly trained experienced athletes | Q42141514 | ||
| Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin | Q42251650 | ||
| Obstructive sleep apnea syndrome induced by testosterone administration | Q42258681 | ||
| An acute myocardial infarction occurring in an anabolic steroid user. | Q42285953 | ||
| Acute metabolic effects of exercise in bodybuilders using anabolic steroids | Q42409513 | ||
| Increased left ventricular mass in a bodybuilder using anabolic steroids | Q42410078 | ||
| Exposure to anabolic-androgenic steroids shortens life span of male mice | Q42549716 | ||
| Anabolic steroid: effects on strength, body weight, oxygen uptake and spermatogenesis upon mature males | Q43446979 | ||
| Anabolic steroid abuse and cardiac sudden death: a pathologic study | Q43525367 | ||
| Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease | Q43529741 | ||
| Anabolic steroids increase exercise tolerance | Q43606120 | ||
| Body composition and anthropometry in bodybuilders: regional changes due to nandrolone decanoate administration | Q43608904 | ||
| The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. | Q43852953 | ||
| Effect of anabolic steroids on rat heart muscle cells. I. Intermediate filaments | Q43920972 | ||
| Misuse of androgenic-anabolic steroids and human deltoid muscle fibers: differences between polydrug regimens and single drug administration | Q43980136 | ||
| Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy | Q44030256 | ||
| Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease | Q44157255 | ||
| Physiological responses to resistance-exercise in athletes self-administering anabolic steroids | Q44178425 | ||
| Residual effect of an anabolic steroid upon isotonic muscular force | Q44235648 | ||
| Effect of anabolic steroid treatment on endurance | Q44260512 | ||
| Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. | Q44387353 | ||
| Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin | Q44474796 | ||
| Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes | Q44516580 | ||
| Bodybuilders' body composition: effect of nandrolone decanoate. | Q44839066 | ||
| Body composition changes in bodybuilders: a method comparison | Q44839069 | ||
| Anabolic steroid abuse and cardiac death | Q70662510 | ||
| The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity | Q70699430 | ||
| [Changes in muscle power production capacity in power athletes self-administering androgenic anabolic steroids] | Q70709981 | ||
| Reduced high-density lipoprotein-cholesterol in power athletes: use of male sex hormone derivates, an atherogenic factor | Q70712404 | ||
| Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self-administering androgenic and anabolic steroids | Q70748977 | ||
| Muscle ultrastructure after strength training with placebo or anabolic steroid | Q70765853 | ||
| Anabolic steroids and psoriasis exacerbation | Q71330545 | ||
| Male contraception | Q71337567 | ||
| Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate | Q71364578 | ||
| High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use | Q71398410 | ||
| Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone | Q71441780 | ||
| Lipoprotein (a) and cholesterol in body builders using anabolic androgenic steroids | Q71449090 | ||
| Changes in lipoprotein-lipid levels in normal men following administration of increasing doses of testosterone cypionate | Q71498713 | ||
| Anabolic steroid abuse and renal-cell carcinoma | Q71520428 | ||
| Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical training | Q71578736 | ||
| Fat-free mass index in users and nonusers of anabolic-androgenic steroids | Q71580184 | ||
| Child sexual abuse associated with anabolic androgenic steroid use | Q71590872 | ||
| Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis | Q71625359 | ||
| Gymnasium acne | Q71655901 | ||
| Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal | Q71711801 | ||
| Gynaecomastia in bodybuilders | Q71713402 | ||
| Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial | Q71723693 | ||
| Body image and steroid use in male bodybuilders | Q71793898 | ||
| Relative binding affinities of testosterone, 19-nortestosterone and their 5 alpha-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5 alpha-reductive steroid metabolism in the dissociation of "m | Q71843194 | ||
| Cardiovascular complications and anabolic steroids | Q71875461 | ||
| Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users | Q71885486 | ||
| Psychological characteristics of adolescent steroid users | Q72074268 | ||
| Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids | Q72187311 | ||
| Linear keloids resulting from abuse of anabolic androgenic steroid drugs | Q72270238 | ||
| Lack of demonstrated effect of nandrolone on serum lipids | Q72276252 | ||
| Peliosis hepatis in a young adult bodybuilder | Q72305463 | ||
| Anabolic steroid: effects on strength development | Q72346954 | ||
| Reversible azoospermia induced by the anabolic steroid 19-nortestosterone | Q72573373 | ||
| Effect of an anabolic steroid on physical performance of young men | Q72575067 | ||
| Anabolic steroids and blood cell production | Q72645869 | ||
| The effects of anabolic steroids on myocardial structure and cardiovascular fitness | Q72727344 | ||
| Acute hereditary coproporphyria induced by the androgenic/anabolic steroid methandrostenolone (Dianabol) | Q72740378 | ||
| Effect of anabolic steroids on HIV-related wasting myopathy | Q72879650 | ||
| Ultrastructural changes induced by anabolic steroids in liver of trained rats | Q72895619 | ||
| Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients | Q73215906 | ||
| The expression of androgen receptors in human neck and limb muscles: effects of training and self-administration of androgenic-anabolic steroids | Q73421943 | ||
| Effect of androgenic anabolic steroids on sperm quality and serum hormone levels in adult male bodybuilders | Q73676262 | ||
| Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power atheletes, and this effect is potentiated by concomitant use of growth hormone | Q73683927 | ||
| Testosterone-propionate impairs the response of the cardiac capillary bed to exercise | Q73745111 | ||
| Muscle dysmorphia. An underrecognized form of body dysmorphic disorder | Q74034437 | ||
| Anabolic steroids in athelics: crossover double-blind trial on weightlifters | Q55180847 | ||
| Increased Premature Mortality of Competitive Powerlifters Suspected to Have Used Anabolic Agents | Q56638221 | ||
| QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids | Q57800986 | ||
| Violence Toward Women and Illicit Androgenic-Anabolic Steroid Use | Q58171230 | ||
| Human strength and endurance responses to anabolic steroid and training | Q67064018 | ||
| Effect of an anabolic steroid (metandienone) on central and peripheral blood flow in well-trained male athletes | Q67233012 | ||
| Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids | Q67269512 | ||
| Effect of long-term testosterone oenanthate administration on male reproductive function: clinical evaluation, serum FSH, LH, testosterone, and seminal fluid analyses in normal men | Q67311835 | ||
| The effects of large doses of the anabolic steroid, methandrostenolone, on an athlete | Q67314189 | ||
| The effect of anabolic steroids on physical fitness | Q67341980 | ||
| Myocardial cell lesions caused by an anabolic hormone | Q67598989 | ||
| Sequence of Changes in Body Composition Induced by Testosterone and Reversal of Changes After Drug Is Stopped | Q67719113 | ||
| Effect of testosterone on metabolic rate and body composition in normal men and men with muscular dystrophy | Q67728583 | ||
| Psychological and serum homovanillic acid changes in men administered androgenic steroids | Q67768230 | ||
| Anabolic steroids: damages, effect on performance, and on metabolism (author's transl) | Q67774405 | ||
| Effects of Anabolic-Androgenic Steroids on Muscular Strength | Q67901483 | ||
| Effects of training and anabolic steroids on collagen synthesis in dog heart | Q67914460 | ||
| Reversibility of the haemodynamic effects of anabolic steroids in rats | Q67989693 | ||
| Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders | Q68009678 | ||
| [Rhabdomyolysis in a bodybuilder using anabolic steroids] | Q68060375 | ||
| Comparison of the effects of high dose testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men | Q68068870 | ||
| Effects of physical training, methandione and their combination on the lysosomal hydrolytic activities in dog heart | Q68070532 | ||
| The blood pressure response to exercise in anabolic steroid users | Q68149743 | ||
| Deleterious Effects of Anabolic Steroids on Serum Lipoproteins, Blood Pressure, and Liver Function in Amateur Body Builders | Q68347333 | ||
| Anabolic steroids in athletics | Q68498464 | ||
| High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered | Q68690918 | ||
| Homicide and near-homicide by anabolic steroid users | Q68693531 | ||
| The effect of testosterone and anabolic steroids on the skin surface lipids and the population of Propionibacteria acnes in young postpubertal men | Q69017715 | ||
| The effects of anabolic steroids and endurance training on systolic time intervals in the dog | Q69047420 | ||
| Androgenic steroid effects on serum hormones and on maximal force development in strength athletes | Q69074048 | ||
| Anabolic steroids alter the haemodynamic responses of the canine left ventricle | Q69103118 | ||
| Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders | Q69187212 | ||
| The effect of an anabolic steroid on strength and lean body mass | Q69316878 | ||
| Prolonged effects of anabolic steroid upon muscular contractile force | Q69345588 | ||
| The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol | Q69405595 | ||
| Androgenic-anabolic steroid effects on serum thyroid, pituitary and steroid hormones in athletes | Q69414485 | ||
| Aromatization by skeletal muscle | Q69571513 | ||
| Testicular responsiveness to human chorionic gonadotrophin during transient hypogonadotrophic hypogonadism induced by androgenic/anabolic steroids in power athletes | Q69597051 | ||
| One- and two-dimensional echocardiography in bodybuilders using anabolic steroids | Q69627527 | ||
| Lipemic and lipoproteinemic effects of natural and synthetic androgens in humans | Q69688448 | ||
| Adenocarcinoma of prostate in 40-year-old body-builder | Q69887513 | ||
| Spontaneous rupture of the extensor pollicis longus tendon after anabolic steroids | Q70032437 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 513-554 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Sports Medicine | Q15762097 |
| P1476 | title | Effects of androgenic-anabolic steroids in athletes | |
| P478 | volume | 34 |
| Q33710886 | "I Want It All, and I Want It Now": Lifetime Prevalence and Reasons for Using and Abstaining from Controlled Performance and Appearance Enhancing Substances (PAES) among Young Exercisers and Amateur Athletes in Five European Countries. |
| Q92876714 | A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse |
| Q42026255 | A Validated TLC-Densitometric Method for the Determination of Mesterolone in Bulk Material and in Tablets. |
| Q37149192 | A national study of substance use behaviors among NCAA male athletes who use banned performance enhancing substances |
| Q50712679 | A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health. |
| Q36215778 | A ten-year assessment of anabolic steroid misuse among competitive athletes in Puerto Rico. |
| Q36818188 | AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects |
| Q54235015 | AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion. |
| Q34002248 | Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem |
| Q39176842 | Acute myocardial infarction in a young male wrestler: A case report |
| Q89174419 | Adulterated dietary supplements threaten the health and sporting career of up-and-coming young athletes |
| Q38212131 | Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources |
| Q37980791 | Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging |
| Q46353359 | Adverse effect of the anabolic-androgenic steroid mesterolone on cardiac remodelling and lipoprotein profile is attenuated by aerobicz exercise training. |
| Q34098584 | Adverse health effects of anabolic-androgenic steroids |
| Q37756333 | Aging men and lipids |
| Q37171075 | Anabolic agents for improving muscle regeneration and function after injury |
| Q53688645 | Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review. |
| Q33284580 | Anabolic androgenic steroids induce micronuclei in buccal mucosa cells of bodybuilders |
| Q37611627 | Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient |
| Q34439229 | Anabolic steroids after total knee arthroplasty. A double blinded prospective pilot study |
| Q37974238 | Anabolic steroids and cardiovascular risk. |
| Q34419302 | Anabolic steroids in patients undergoing total knee arthroplasty. |
| Q37495640 | Anabolic steroids: dependence and complications of chronic use. |
| Q36966299 | Anabolic-androgenic steroid effects on nociception and morphine antinociception in male rats |
| Q35710533 | Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review |
| Q45974435 | Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease. |
| Q91670227 | Androgens and Anemia: Current Trends and Future Prospects |
| Q62089247 | Androgens modulate song effort and aggression in Neotropical singing mice |
| Q37995009 | Andrological aspects of physical exercise and sport medicine |
| Q50921739 | Aromatase inhibitors and bipolar mood disorder: a case report. |
| Q36550028 | Assessment of some cardiovascular risk factors in predialysis chronic kidney disease patients in Southern Nigeria |
| Q39920378 | Association between narcotic use and anabolic-androgenic steroid use among American adolescents |
| Q57423582 | Avaliação descritiva sobre o uso de esteroides anabolizantes e seu efeito sobre as variáveis bioquímicas e neuroendócrinas em indivíduos que praticam exercício resistido |
| Q35036928 | Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation |
| Q35196475 | Bone vs. fat: embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts |
| Q51443001 | Cardiac autonomic dysfunction in anabolic steroid users. |
| Q40190092 | Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. |
| Q36736118 | Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement |
| Q24556667 | Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior |
| Q38110504 | Characterization and regulation of mechanical loading-induced compensatory muscle hypertrophy |
| Q47618024 | Chronic Exercise Reduces CETP and Mesterolone Treatment Counteracts Exercise Benefits on Plasma Lipoproteins Profile: Studies in Transgenic Mice |
| Q35897666 | Chronic Exposure to Androgenic-Anabolic Steroids Exacerbates Axonal Injury and Microgliosis in the CHIMERA Mouse Model of Repetitive Concussion. |
| Q30433566 | Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis |
| Q50289113 | Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders |
| Q36243371 | Congenital Adrenal Hyperplasia in an Elite Female Soccer Player; What Sports Medicine Clinicians Should Know about This? |
| Q36583721 | Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis |
| Q56554879 | Consequences of the Use of Anabolic-Androgenic Steroids on Female Athletes’ Fertility |
| Q24304505 | Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. |
| Q42918550 | Correlation of product ion profiles with molecular structures of androgenic and anabolic steroids in ESI MS/MS |
| Q21254616 | Current anti-doping policy: a critical appraisal |
| Q38158183 | Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysis |
| Q28383546 | Current understanding of chronic traumatic encephalopathy |
| Q42041448 | Delayed diagnosis of a cerebrovascular accident associated with anabolic steroid use. |
| Q95446736 | Detection and characterization of urinary metabolites of boldione by LC-MS/MS. Part I: Phase I metabolites excreted free, as glucuronide and sulfate conjugates, and released after alkaline treatment of the urine |
| Q33705651 | Detection and confirmation of 60 anabolic and androgenic steroids in equine plasma by liquid chromatography‐tandem mass spectrometry with instant library searching |
| Q46781742 | Deterioration of glomerular endothelial surface layer and the alteration in the renal function after a growth promoter boldenone injection in rabbits |
| Q37697595 | Determination of DNA damage and telomerase activity in stanozolol-treated rats. |
| Q51572920 | Development and application of a high-throughput sample cleanup process based on 96-well plate for simultaneous determination of 16 steroids in biological matrices using liquid chromatography-triple quadrupole mass spectrometry. |
| Q35173334 | Development and validation of the appearance and performance enhancing drug use schedule |
| Q47892779 | Developmental programming: Interaction between prenatal BPA and postnatal overfeeding on cardiac tissue gene expression in female sheep |
| Q36770973 | Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expression |
| Q34053721 | Developmental programming: prenatal BPA treatment disrupts timing of LH surge and ovarian follicular wave dynamics in adult sheep |
| Q46694149 | Diverse effects of stanozolol in C57BL/6J and A/J mouse strains |
| Q38677404 | Do anabolic-androgenic steroids have performance-enhancing effects in female athletes? |
| Q88014097 | Do athletes have a right to access data in their Athlete Biological Passport? |
| Q26825805 | Do fat supplements increase physical performance? |
| Q33503495 | Doping and effects of anabolic androgenic steroids on the heart: histological, ultrastructural, and echocardiographic assessment in strength athletes |
| Q37805634 | Doping and musculoskeletal system: short-term and long-lasting effects of doping agents |
| Q38589015 | Doping in sport and exercise: anabolic, ergogenic, health and clinical issues |
| Q83312021 | Doping use among tertiary education students in six developed countries |
| Q42142825 | Echocardiographic findings in power athletes abusing anabolic androgenic steroids |
| Q33901050 | Effect of anabolic-androgenic steroids and glucocorticoids on the kinetics of hAR and hGR nucleocytoplasmic translocation |
| Q43254311 | Effect of dihydrotestosterone on cultured human tenocytes from intact supraspinatus tendon |
| Q44141439 | Effect of exogenous testosterone on oxidative status of the testes in adult male rats |
| Q34108247 | Effect of low-level laser therapy on proliferation, differentiation, and adhesion of steroid-treated osteoblasts |
| Q51913928 | Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects. |
| Q30525602 | Effective separation and simultaneous analysis of anabolic androgenic steroids (AAS) in their pharmaceutical formulations by a validated TLC-densitometry method |
| Q30235442 | Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis |
| Q36189831 | Effects of High-Intensity Training of Professional Runners on Myocardial Hypertrophy and Subclinical Atherosclerosis |
| Q37340570 | Effects of Nandrolone Stimulation on Testosterone Biosynthesis in Leydig Cells |
| Q46878321 | Effects of anabolic androgenic steroids on sleep patterns of individuals practicing resistance exercise |
| Q35049342 | Effects of anabolic steroids and high-intensity aerobic exercise on skeletal muscle of transgenic mice |
| Q100669130 | Effects of lifelong testosterone exposure on health and disease: a Mendelian randomization study |
| Q34160098 | Effects of long term supplementation of anabolic androgen steroids on human skeletal muscle |
| Q31143786 | Endurance exercise and conjugated linoleic acid (CLA) supplementation up-regulate CYP17A1 and stimulate testosterone biosynthesis |
| Q36148561 | Estrogenic encounters: how interactions between aromatase and the environment modulate aggression |
| Q36861790 | Exogenous Testosterone, Aging, and Changes in Behavioral Response of Gonadally Intact Male Mice |
| Q28287145 | External and internal factors influencing happiness in elite collegiate athletes |
| Q37222716 | Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers |
| Q35519737 | First-degree relatives with behavioural adverse effects on statins |
| Q37277619 | Gene expression in hair follicle dermal papilla cells after treatment with stanozolol. |
| Q42725671 | Gene expression profiling in human whole blood samples after controlled testosterone application and exercise |
| Q37481427 | Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse |
| Q24797578 | Genomic studies of mood disorders -- the brain as a muscle? |
| Q64963508 | Heart Reaction to Nandrolone Decanoate plus Two Different Intensities of Endurance Exercise: Electrocardiography and Stereological Approach. |
| Q34902148 | High-dose testosterone propionate treatment reverses the effects of endurance training on myocardial antioxidant defenses in adolescent male rats. |
| Q35123392 | Histological changes in testes of rats treated with testosterone, nandrolone, and stanozolol |
| Q36972836 | Homicidality and Psychosis Caused by an Over-the-Counter Performance-Enhancing Supplement Containing Dendrobium Extract and L-Dopa |
| Q38044615 | Hormones as doping in sports. |
| Q33905686 | Illicit anabolic-androgenic steroid use |
| Q36898441 | Illicit drugs and cardiac arrhythmias in athletes |
| Q53351046 | Impact of single-dose nandrolone decanoate on gonadotropins, blood lipids and HMG CoA reductase in healthy men. |
| Q42162610 | Impaired Physical Performance and Clinical Responses after a Recreational Bodybuilder's Self-Administration of Steroids: A Case Report |
| Q36830258 | In vitro androgen bioassays as a detection method for designer androgens |
| Q39538066 | In vivo MRI evaluation of anabolic steroid precursor growth effects in a guinea pig model. |
| Q46886528 | Increased mortality rate and suicide in Swedish former elite male athletes in power sports |
| Q36122245 | Influence of nandrolone decanoate administration on serum lipids and liver enzymes in rats |
| Q47554638 | Investigating Gender Differences under Time Pressure in Financial Risk Taking |
| Q91785381 | Knowledge of and Attitudes Toward the Use of Anabolic-Androgenic Steroids among the Population of Jeddah, Saudi Arabia |
| Q88780141 | Left atrial myocardial dysfunction after chronic abuse of anabolic androgenic steroids: a speckle tracking echocardiography analysis |
| Q50578186 | Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via re-balance of brain neurotransmitters, up-regulation of Nrf2/HO-1 pathway, and down-regulation of TNFR1 expression. |
| Q24649521 | Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? |
| Q37375551 | Making all the children above average: ethical and regulatory concerns for pediatricians in pediatric enhancement research |
| Q38261724 | Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and/or mitigation of adverse effects |
| Q56523002 | Male mating competitiveness and age-dependent relationship between testosterone and social rank in bighorn sheep |
| Q52868396 | Micronucleus as biomarkers of cancer risk in anabolic androgenic steroids users. |
| Q37494090 | Modulatory effect of gonadotropins on rats' ovaries after nandrolone decanoate administration: a stereological study |
| Q38383101 | Molecular effects of supraphysiological doses of doping agents on health |
| Q34194015 | Multivitamin and protein supplement use is associated with positive mood states and health behaviors in US Military and Coast Guard personnel |
| Q36299949 | National Athletic Trainers' Association position statement: anabolic-androgenic steroids |
| Q64256832 | Neuroendocrine Whiplash: Slamming the Breaks on Anabolic-Androgenic Steroids Following Repetitive Mild Traumatic Brain Injury in Rats May Worsen Outcomes |
| Q35710568 | Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review. |
| Q38850727 | New oxymesterone metabolites in human by gas chromatography-tandem mass spectrometry and their application for doping control |
| Q36891709 | Nightmares: Prevalence among the Finnish General Adult Population and War Veterans during 1972-2007. |
| Q88583205 | Noble metal nanostructures in optical biosensors: Basics, and their introduction to anti-doping detection |
| Q35656141 | Nonprescription steroids on the Internet |
| Q38930245 | Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health |
| Q37775775 | Novel strategies for tracing the exposure of meat cattle to illegal growth-promoters. |
| Q33564262 | Nutrition, Pharmacological and Training Strategies Adopted by Six Bodybuilders: Case Report and Critical Review |
| Q22251210 | Nutritional Supplements and Ergogenic Aids |
| Q51762747 | Pharmacokinetics of boldenone and stanozolol and the results of quantification of anabolic and androgenic steroids in race horses and nonrace horses. |
| Q45099443 | Pharmacokinetics of stanozolol in Thoroughbred horses following intramuscular administration |
| Q47811763 | Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls |
| Q38067480 | Physiology, pathology and pharmacology of the male reproductive system |
| Q50045237 | Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Depot Testosterone Cypionate in Healthy Male Subjects |
| Q37061417 | Potential biomarkers of ageing. |
| Q30408099 | Potential for sexual conflict assessed via testosterone-mediated transcriptional changes in liver and muscle of a songbird |
| Q33878751 | Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids. |
| Q55437017 | Prevalence and awareness of Anabolic Androgenic Steroids (AAS) among gymnasts in the western province of Riyadh, Saudi Arabia. |
| Q38244410 | Prevalence of doping use in elite sports: a review of numbers and methods |
| Q38207129 | Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review |
| Q43060741 | Prolonged treatment with the anabolic-androgenic steroid stanozolol increases antioxidant defences in rat skeletal muscle |
| Q36075213 | Pulmonary rehabilitation in chronic obstructive pulmonary disease |
| Q50980529 | Quantitative model of hematologic and plasma volume responses after ascent and acclimation to moderate to high altitudes. |
| Q28602465 | Reactive oxygen species: players in the cardiovascular effects of testosterone |
| Q36956812 | Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase |
| Q46098254 | Relationships between hormones, physiological performance and immunocompetence in a color-polymorphic lizard species, Podarcis melisellensis |
| Q58590483 | Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects |
| Q37418611 | Risk profile of male college athletes who use performance-enhancing substances |
| Q92988384 | Role of Testosterone in the Treatment of Cardiovascular Disease |
| Q37249420 | Severe cholestasis and renal failure associated with the use of the designer steroid Superdrol (methasteron): a case report and literature review |
| Q37216745 | Sex-specific effect of the anabolic steroid, 17α-methyltestosterone, on inhibitory avoidance learning in periadolescent rats |
| Q38623668 | Sexual orientation, bullying for being labeled gay or bisexual, and steroid use among US adolescent boys |
| Q36597826 | Sheep models of polycystic ovary syndrome phenotype. |
| Q83197773 | Short QT interval: A novel predictor of androgen abuse in strength trained athletes |
| Q35927740 | Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA reductase |
| Q34590954 | Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones |
| Q46278906 | Stanozolol Decreases Bone Turnover Markers, Increases Mineralization, and Alters Femoral Geometry in Male Rats |
| Q35449237 | Stem cell activation in adults can reverse detrimental changes in body composition to reduce fat and increase lean mass in both sexes |
| Q61598495 | Steroids, psychosis and poly-substance abuse |
| Q50530287 | Structural changes and immunohistochemical localisation of epidermal growth factor receptor in the true vocal fold of female albino rats administered anabolic, androgenic steroids, and effects of anti-androgen therapy. |
| Q51040629 | Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns. |
| Q93137613 | Sudden cardiac death in anabolic androgenic steroids abuse: case report and literature review |
| Q35180366 | Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug |
| Q52141708 | Tanshinone I Enhances Neurogenesis in the Mouse Hippocampal Dentate Gyrus via Increasing Wnt-3, Phosphorylated Glycogen Synthase Kinase-3β and β-Catenin Immunoreactivities. |
| Q46148782 | Tendon structural adaptations to load exercise are inhibited by anabolic androgenic steroids. |
| Q34130847 | Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone |
| Q43171849 | Testosterone and secondary hypertension: new pieces to the puzzle. |
| Q58304502 | Testosterone replacement therapy and cardiovascular risk factors modification |
| Q45375420 | Testosterone stimulates myoglobin expression in different muscles of the mouse |
| Q58707392 | The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity |
| Q40784387 | The Paternal Provisioning Hypothesis: effects of workload and testosterone production on men's musculature. |
| Q44285801 | The anabolic steroid nandrolone enhances motor and sensory functional recovery in rat median nerve repair with long interpositional nerve grafts |
| Q37165438 | The anabolic steroids testosterone propionate and nandrolone, but not 17alpha-methyltestosterone, induce conditioned place preference in adult mice |
| Q36509830 | The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications |
| Q36893601 | The coagulation system in endocrine disorders: a narrative review. |
| Q41411146 | The cutaneous bacterial microflora of the bodybuilders using anabolic-androgenic steroids |
| Q34574338 | The diagnostic dilemma of pathological appearance and performance enhancing drug use |
| Q47146618 | The interaction effects of resistance training and sustanon abuse on liver antioxidant activities and serum enzymes in male rats |
| Q38977809 | The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia) |
| Q37821008 | Therapeutic effects of anabolic androgenic steroids on chronic diseases associated with muscle wasting |
| Q33909292 | Threatened fertility and gonadal function after a polytraumatic, life-threatening injury |
| Q33872639 | Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications |
| Q24655493 | Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys |
| Q37829732 | Two emerging concepts for elite athletes: the short-term effects of testosterone and cortisol on the neuromuscular system and the dose-response training role of these endogenous hormones |
| Q90311996 | Uncovering sex-specific mechanisms of action of testosterone and redox balance |
| Q34135987 | Unique distribution of aromatase in the human brain: In vivo studies with PET and [N‐methyl‐11C]vorozole |
| Q33903707 | Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study. |
| Q58258644 | Voltammetric Sensor Based on a Double-Layered Molecularly Imprinted Polymer for Testosterone |
| Q39288876 | What can allostasis tell us about anabolic-androgenic steroid addiction? |
| Q35330680 | Why we should allow performance enhancing drugs in sport |
| Q42670321 | Women's self-rated attraction to male faces does not correspond with physiological arousal |
| Q80142216 | [Doping. High-tech cheating in sport] |
| Q46492409 | p53 and Bcl-2expression in response to boldenone induced liver cells injury. |
Search more.